Vakiener Victoria
- SEC CIK
- 0001826263
In the past year, 1 open-market sale filing worth $679.5K and no purchases.
Current role at each company
- ARWR Arrowhead Pharmaceuticals, Inc.Directoras of Dec 23, 2025
- CMRX Chimerix IncDirectoras of Apr 21, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $679.5K
- 1 filing
- Net
- −$679.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Vakiener Victoria as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARWR Arrowhead Pharmaceuticals, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 (view filing) | Dec 19 | 4 days | Vakiener VictoriaDirector | SSale | −10.0K | $67.68 | −$679.5K | −21.9%35.7K after | 3 lots10b5-1 |
| Dec 18, 2024 (view filing) | Dec 16 | 2 days | Vakiener VictoriaDirector | SSale | −8.99K | $21.91 | −$197.1K | −29.8%21.2K after | 10b5-1 |
| May 6, 2024 (view filing) | May 2 | 4 days | Vakiener VictoriaDirector | SSale | −1.80K | $23.31 | −$41.9K | −5.6%30.2K after | 10b5-1 |
| Jan 16, 2024 (view filing) | Jan 11 | 5 days | Vakiener VictoriaDirector | SSale | −4.72K | $38.10 | −$179.8K | −12.9%32.0K after | 2 lots10b5-1 |
| Oct 2, 2023 (view filing) | Sep 28 | 4 days | Vakiener VictoriaDirector | SSale | −1.55K | $26.33 | −$40.8K | −6.7%21.7K after |